Street Calls of the Week
Investing.com reports on a week of significant market-moving rating changes involving PG&E Corp, Netflix, Moderna, BMW, and Humana. UBS downgraded PG&E to Neutral, slashing its price target by 26%, from $19 to $14, citing a lack of regulatory catalyst in California's wildfire liability reform. HSBC cut Netflix's price target from $96 to $76, citing intensifying competition and a content-spending burden.
Rothschild Redburn downgraded Moderna to Sell, setting a price target of $81, signaling a 58% downside from current levels. HSBC also downgraded BMW, citing China business deterioration, and Barclays upgraded Humana to Overweight, raising its price target to $515.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
